Skip to NavigationSkip to content

Pharmafile - Research and Development News

Shares in the Texas based biotech Molecular Templates have soared after the company announced that they would be collaborating with Japanese pharma...
Astellas has revealed new Phase 3 data for roxadustat in the treatment of chronic kidney disease (CKD) in patients with anaemia not on dialysis,...
Almirall has announced that the European Commission has approved its interleukin-23 (IL-23) inhibitor Ilumetri (tildrakizumab) for the treatment of...
The National Institute for health and Care Excellence (NICE) has rejected Novartis’ CAR-T therapy Kymriah for use in adults with relapsed or...
Novartis has announced it is to relocate its operations in Arnhem in the Netherlands to the capital city of Amsterdam, according to Dutch regional...
The Anglo-Swedish multinational AstraZeneca is moving towards becoming a major healthcare provider in China as part of an effort to expand the...
The US Food and Drug Administration is set to introduce a requirement that all healthcare providers be offered educational training in pain...
Cancer Research UK has announced a £14 million investment to build a new hub in London for cancer research and treatment to create “a global centre...
Sanofi’s Dupixent (dupilumab) has made a strong showing as a monotherapy at Phase 3 in the treatment of moderate-to-severe atopic dermatitis in...
UCB has revealed new findings for its products Cimzia and bimekizumab in the treatment of moderate-to-severe chronic plaque psoriasis.
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches